HTA218 Reimbursement Mechanisms Used by CAR-T Therapies in the EU5 (2018–2023)
Abstract
Authors
E Geldman O. Daykin-Pont R Newberry A Loos D Wolfert
E Geldman O. Daykin-Pont R Newberry A Loos D Wolfert
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now